CLASS II Device recall · Reported 19 Mar 2014 · FDA Enforcement Report

G2001: Line Draw, Luer slip syringe (heparin concentration: 23.5 I.U recalled

Smiths Medical ASD is recalling G2001: Line Draw, Luer slip syringe (heparin concentration: 23.5 I.U. per mL) with, distributed in 40 states. The recall was initiated on 22 Nov 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes2548332
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1192-2014
FDA event ID
66837
Recalling firm
Smiths Medical ASD, Keene, NH
Classification
Class II
Status
Terminated
Recall initiated
22 Nov 2013
FDA classified
12 Mar 2014
Reported
19 Mar 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

22 Nov 2013Recall initiated by company
12 Mar 2014Classified by FDA+110 days
19 Mar 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

issue with the plunger tip of the Portex¿ Arterial Blood Sampling Line Draw Syringes

Product as listed by the FDA

G2001: 3 mL Line Draw, Luer slip syringe (heparin concentration: 23.5 I.U. per mL) with Filter-Pro¿ device, Needle-Pro¿ Device and 23G x 1 needle Arterial Blood Sampling Line Draw Syringes are sterile, single-use devices, in-vitro diagnostic devices used for the drawing of arterial blood via an arterial line. The product is not for injection.

Where it was distributed

Worldwide Distribution - USA including AL, AZ, CA, CO, CT, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV. Internationally to Australia, Austria, Belgium, Belize, Brazil, Canada, Czech Republic, Denmark, England, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Netherlands, Norway, Poland, Scotland, Spain, and Sweden.

AlabamaArizonaCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIowaIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMichiganMinnesotaMissouri

Questions about this recall

Why was it recalled?

issue with the plunger tip of the Portex¿ Arterial Blood Sampling Line Draw Syringes

Which lots are affected?

2548332

Where was it sold?

Worldwide Distribution - USA including AL, AZ, CA, CO, CT, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV. Internationally to Australia, Austria, Belgium, Belize, Brazil, Canada, Czech Republic, Denmark, England, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Netherlands, Norway, Poland, Scotland, Spain, and Sweden.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

12 other products · FDA event 66837

This product is part of a recall event; the main page for the event is 4042LH: Line Draw, Luer lock syringe (heparin concentration: 7 I.U recalled.

More recalls from Smiths Medical ASD

All 284

Other Test Kits & Diagnostics recalls

All 2,656